Mirikizumab - Intravenous (IV): clinical trials recruiting now
3
Recruiting trials
7
Conditions studied
15
US states with sites
10
Countries
Phase breakdown
Phase 2 2
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Crohn's disease · Mirikizumab - Intravenous (IV) for Crohn's disease | 3 |
| Crohn Disease | 2 |
| Colitis, Ulcerative | 1 |
| Pouch, Ileal | 1 |
| Pouches, Ileoanal | 1 |
| Pouchitis | 1 |
| Ulcerative colitis | 1 |
Recruiting trials involving Mirikizumab - Intravenous (IV)
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
Common questions
How many recruiting trials involve Mirikizumab - Intravenous (IV)?
3 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.